First Treatment for Teens with Severe Alopecia Has Been Approved in the U.S. and Canada

Over the summer, the U.S. Food and Drug Administration (FDA) approved a new treatment for teens with severe alopecia (a disorder in which the immune system attacks hair follicles, causing serious hair loss). The drug, called Litfulo, inhibits the pathway in the immune system that attacks the hair follicles. It helps to lower inflammation at the follicle and has shown significant hair regrowth—including scalp hair, eyebrows, and eyelashes—in patients who participated in clinical trials. It is the first FDA-approved treatment for kids and teens 12 and up. Recently, Litfulo also received approval from Health Canada and the UK’s Medicines and Healthcare products Regulatory Agency.



Source link